Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
United European Gastroenterology Journal|April 26, 2019
Appropriateness of pancreatic resection in high-risk individuals for familial pancreatic ductal adenocarcinoma: a patient-level meta-analysis and proposition of the Beaujon scoreLouis de Mestier, Marie Muller, Jérôme Cros, et al.
Annals of Surgery|September 5, 2014
Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in PlaceLouis de Mestier, Sébastien Gaujoux, Jérôme Cros, et al.
Endocrine-Related Cancer|July 23, 2020
Critical appraisal of MGMT in digestive NET treated with alkylating agentsLouis de Mestier, Anne Couvelard, Anela Blazevic, et al.
World Journal of Gastrointestinal Oncology|June 18, 2014
Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A reviewLouis de Mestier, Gilles Manceau, Cindy Neuzillet, et al.
Abdominal Radiology (New York)|April 21, 2026
Mucinous vs. non-mucinous pancreatic cysts: diagnostic keys on CT and MRIMarco Dioguardi Burgio, Maxime Ronot, Caroline Chassaing, et al.
Cancers|February 10, 2021
Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine NeoplasmsCaroline Lacombe, Ophélie De Rycke, Anne Couvelard, et al.
Neuroendocrinology|May 10, 2019
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine TumorLouis de Mestier, Thomas Walter, Camille Evrard, et al.
Therapeutic Advances in Medical Oncology|November 1, 2021
Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary mucinous ovarian carcinomaAlice de Malet, Magali Svrcek, Anne Kerbaol, et al.
Endocrine-Related Cancer|January 13, 2025
Temporal increase in Ki-67 index in patients with pancreatic neuroendocrine tumoursPauline Bourdeleau, Johanna Pokossy-Epée, Olivia Hentic, et al.
Endocrine-Related Cancer|May 12, 2021
Alkylating agent rechallenge in metastatic pancreatic neuroendocrine tumorsOphélie De Rycke, Thomas Walter, Marine Perrier, et al.
Pageof 13